Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diagnosis and screening of cancer. Abcodia develops products for the detection of colorectal cancer, pancreatic cancer and lung cancer. The company serves diagnostic, pharmaceutical and technology companies for validation and discovery of ethical biomarkers. It collaborates with global commercial, academic and charity partners. Abcodia is headquartered in Cambridge, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abcodia Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Abcodia Ltd Company Overview
- Abcodia Ltd Company Snapshot
- Abcodia Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Abcodia Ltd - Pipeline Analysis Overview
- Abcodia Ltd - Key Facts
- Abcodia Ltd - Major Products and Services
- Abcodia Ltd Pipeline Products by Development Stage
- Abcodia Ltd Pipeline Products Overview
- Biomarker Test - Liver Cancer
- Biomarker Test - Liver Cancer Product Overview
- Diagnostic Assay - Colorectal Cancer
- Diagnostic Assay - Colorectal Cancer Product Overview
- Diagnostic Assay - Haematological Cancer
- Diagnostic Assay - Haematological Cancer Product Overview
- Diagnostic Assay - Lung Cancer
- Diagnostic Assay - Lung Cancer Product Overview
- Diagnostic Assay - Oesophageal Cancer
- Diagnostic Assay - Oesophageal Cancer Product Overview
- Diagnostic Assay - Pancreatic Cancer
- Diagnostic Assay - Pancreatic Cancer Product Overview
- MCM Test - Lung Cancer
- MCM Test - Lung Cancer Product Overview
- Molecular Biomarker - Diabetes
- Molecular Biomarker - Diabetes Product Overview
- Molecular Biomarker - Osteoporosis
- Molecular Biomarker - Osteoporosis Product Overview
- Molecular Biomarker - Rheumatoid Arthritis
- Molecular Biomarker - Rheumatoid Arthritis Product Overview
- Abcodia Ltd - Key Competitors
- Abcodia Ltd - Key Employees
- Abcodia Ltd - Locations And Subsidiaries
- Head Office
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Grail Inc
- CellMax Life Inc
- Biodesix Inc